Application 207055
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYONANZ | ETHINYL ESTRADIOL; NORETHINDRONE | TABLET;ORAL-28 | 0.035MG;0.5MG | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65862-899 | Cyonanz | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-899 | Cyonanz | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-899 | Cyonanz | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-899 | Cyonanz | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-899 | Cyonanz | Norethindrone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |